Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
Display:
EU contract did not leave time to fix vaccine hiccups -AstraZeneca CEO

AstraZeneca's Chief Executive on Tuesday said the European Union's late decision to strike a contract with the drugmaker to supply COVID-19 vaccines, months after Britain, meant the company did not have enough time to iron out glitches in setting up production lines with external partners.

"We are basically two months behind where we wanted to be," Pascal Soriot told German daily Die Welt in an interview, when asked about delayed deliveries in Europe.

"And the issue here is we've had also teething issues like.this in the UK supply chain," he added. "As for Europe, we are three months behind in fixing those glitches."

...

In August last year, the EU agreed to purchase 300 million doses of AstraZeneca's vaccine for 750 million euros, with an option for an additional 100 million.

That was after Britain in May secured 100 million doses for 84 million pounds and the United States, also that month, secured 300 million doses for up to $1.2 billion.

Soriot, however, said the volumes agreed with the EU were not binding.

Never ever read so many much Bull in a short article ... ‼️

That's best effort??

Purchase price
EU €2.50
UK £0.84
US $4.-
I'm sure the above doesn't tell the whole story of the contract. AstraZeneca has excellent outsource partners in Europe ... it seems more likely the vaccine didn't perform or met FDA Standards ... yet ... thus no build-up of stock.

FDA: COVID-19 vaccines in development - Jan. 15, 2021

Amnesia and Gaza Genocide

by Oui (Oui) on Mon Feb 1st, 2021 at 02:37:27 PM EST

Others have rated this comment as follows:

Display:

Occasional Series